 "Govt fixes ceiling prices of 849 formulations till Nov 2017")
The government has fixed the ceiling prices of 849 formulations, including two coronary stents, under revised Schedule I, based on National List of Essential Medicines, 2015," Minister of State for Chemicals & Fertilisers Mansukh L Mandaviya said in a written reply in Rajya Sabha.
The National Pharmaceuticals Pricing Authority (NPPA) fixes the ceiling prices of medicines listed in the Drugs (Prices Control) Order, 2013 (DPCO 2013), he added.
Also Read
Out of the 849 formulations, the ceiling prices of 59 formulations were reduced by above 40 per cent with respect to maximum price, Mandaviya said.
In case of 24 formulations, the slab wise percentage reduction with respect to maximum price was between 35-40 per cent, he added.
The prices of 233 formulations were reduced by up to five per cent, Mandaviya said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%